Ginkgo Bioworks Holdings Inc at JPMorgan Healthcare Conference (Virtual) Transcript
All right, good afternoon. Welcome, everybody, to our panel on synthetic biology. We've got a great group of speakers with us today. Quick round of introductions from JPMorgan. It's myself and Rachel from our team. We've got (inaudible) from [Capitol Street]. And then for our panelists, we've got Max Bronstein from the White House Office of Science and Technology. We've got Jason Kelly from Ginkgo; Sri Kosaraju from Inscripta; and Gregory Yep from International Flavors & Fragrances.
I thought to kick it off, maybe each of you could just give us a quick overview of your respective companies and positions and how it relates to synthetic biology. Max, we'll start with you coming out of the White House Office of Science and Technology. Talk a little bit about your role in the synthetic biology universe.
Well, thanks very much for having me Tycho. And I'm just excited to be here at JPMorgan. I'm the Assistant Director for Health Innovation at OSTP. And I've been doing
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
